Coen Steven P. 4
4 · Ginkgo Bioworks Holdings, Inc. · Filed Dec 16, 2025
Insider Transaction Report
Form 4
Coen Steven P.
See remarks
Transactions
- Exercise/Conversion
Class A Common Stock
2025-12-12+1,174→ 7,912 total - Exercise/Conversion
Class A Common Stock
2025-12-12+312→ 8,224 total - Sale
Class A Common Stock
2025-12-15$8.89/sh−736$6,540→ 7,488 total - Exercise/Conversion
Restricted Stock Units
2025-12-12−1,174→ 9,992 total→ Class A Common Stock (1,174 underlying) - Exercise/Conversion
Restricted Stock Units
2025-12-12−312→ 4,223 total→ Class A Common Stock (312 underlying)
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- [F2]Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.
- [F3]The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.
- [F4]The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.